Simple Summary Stereotactic body radiation therapy (SBRT) is currently used to treat lung
metastasis, particularly in the setting of oligometastatic disease. Objective of this treatment is …

Background Stereotactic body radiotherapy (SBRT) for oligometastatic disease is
characterized by an excellent safety profile; however, experiences are mostly based on …

Exhaustive criteria and definitive data to identify the ideal lung oligometastatic patient as a
candidate for stereotactic body radiotherapy (SBRT) are lacking. Three distinct cohorts of …

Purpose To assess the clinical results in terms of local control, toxicity, failure pattern and
toxicity of SBRT in oligometastatic patients with inoperable lung metastases. Methods Forty …

Background Data in the literature suggest the existence of oligometastatic disease, a state in
which metastases are limited in number and site. Different kinds of local therapies have …

Background: Stereotactic body radiotherapy (SBRT) for pulmonary oligometastatic disease
achieves excellent treatment outcomes in terms of local control and toxicity. Patients treated …

Purpose The oligometastatic stage is an intermediate stage of cancer between the localized
stage and polymetastatic stage. The prognosis of patients in this stage also appears to be …

Introduction Hypofractionated stereotactic body radiotherapy (SBRT) is an emerging
noninvasive technique for the treatment of oligometastatic cancer. The use of small numbers …

Background and purpose Stereotactic ablative radiotherapy (SABR; or stereotactic body
radiotherapy, SBRT) emerges as treatment option for pulmonary oligometastatic disease …

Objectives The current literature on stereotactic body radiotherapy (SBRT) for
oligometastatic disease is characterized by small patient cohorts with heterogeneous …